As an active and predominant blood leukocyte population, granulocytes infiltrate into injured spinal cord and produce pro-inflammatory mediators to aggravate neuroinflammation. In the current study, we identify the role of the T1R1/T1R3 receptor in granulocyte-mediated neuroinflammation in a rat spinal cord injury (SCI) model. We found that T1R1 and T1R3 were substantially expressed in both circulating and infiltrating granulocytes. In vitro stimulation of T1R1/T1R3 receptor with L-serine notably reduced production of reactive oxygen species (ROS) and several pro-inflammatory cytokines. To evaluate the role of T1R1/T1R3 receptor in vivo, gurmarin, a selective T1R3 inhibitor, was injected into rats before and after SCI. Gurmarin administration significantly upregulated expression of interleukin (IL)-1β, IL-6, myeloperoxidase, and matrix metallopeptidase 9, as well as production of ROS in infiltrating granulocytes. Signal pathway analysis revealed that gurmarin promoted nuclear factor (NF)-κβ signaling in infiltrating granulocytes. Consistently, cell apoptosis and inflammatory mediator levels at the injury sites were increased by gurmarin, together with higher T lymphocyte recruitment. Our research indicates that the T1R1/T1R3 receptor is an anti-inflammatory receptor for infiltrating granulocytes after SCI. Simulation of T1R1/T1R3 receptor might be a prospective, or at least a supplemental, therapeutic approach to controlling neuroinflammation to promote functional recovery.
ZhangN., YinY., XuS.J., WuY.P., and ChenW.S. (2012). Inflammation & apoptosis in spinal cord injury. Indian J. Med. Res., 135, 287–296.
3.
TaokaY., OkajimaK., UchibaM., MurakamiK., KushimotoS., JohnoM., NaruoM., OkabeH., and TakatsukiK. (1997). Role of neutrophils in spinal cord injury in the rat. Neuroscience, 79, 1177–1182.
4.
SaiwaiH., OhkawaY., YamadaH., KumamaruH., HaradaA., OkanoH., YokomizoT., IwamotoY., and OkadaS. (2010). The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am. J. Pathol., 176, 2352–2366.
5.
BastienD., Bellver LandeteV., LessardM., VallieresN., ChampagneM., TakashimaA., TremblayM.E., DoyonY., and LacroixS. (2015). IL-1alpha gene deletion protects oligodendrocytes after spinal cord injury through upregulation of the survival factor Tox3. J. Neurosci., 35, 10,715–10,730.
6.
LeeJ.Y., KimH.S., ChoiH.Y., OhT.H., and YuneT.Y. (2012). Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood–spinal cord barrier after spinal cord injury. Brain, 135, 2375–2389.
7.
NguyenH.X., O'BarrT.J., and AndersonA.J. (2007). Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J. Neurochem., 102, 900–912.
8.
DinkelK., DhabharF.S., and SapolskyR.M. (2004). Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures. Proc. Natl. Acad. Sci. U. S. A., 101, 331–336.
9.
BaoF., FlemingJ.C., GolshaniR., PearseD.D., KasabovL., BrownA., and WeaverL.C. (2011). A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury. J. Neurotrauma, 28, 1035–1049.
10.
KubotaK., SaiwaiH., KumamaruH., MaedaT., OhkawaY., ArataniY., NaganoT., IwamotoY., and OkadaS. (2012). Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury. Spine (Phila Pa 1976), 37, 1363–1369.
11.
KangJ., JiangM.H., MinH.J., JoE.K., LeeS., KarinM., YuneT.Y., and LeeS.J. (2011). IKK-beta-mediated myeloid cell activation exacerbates inflammation and inhibits recovery after spinal cord injury. Eur. J. Immunol., 41, 1266–1277.
12.
WausonE.M., Lorente-RodriguezA., and CobbM.H. (2013). Minireview: Nutrient sensing by G protein-coupled receptors. Mol. Endocrinol., 27, 1188–1197.
13.
WausonE.M., ZaganjorE., LeeA.Y., GuerraM.L., GhoshA.B., BookoutA.L., ChambersC.P., JivanA., McGlynnK., HutchisonM.R., DeberardinisR.J., and CobbM.H. (2012). The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol. Cell, 47, 851–862.
14.
KendigD.M., HurstN.R., BradleyZ.L., MahavadiS., KuemmerleJ.F., LyallV., DeSimoneJ., MurthyK.S., and GriderJ.R. (2014). Activation of the umami taste receptor (T1R1/T1R3) initiates the peristaltic reflex and pellet propulsion in the distal colon. Am. J. Physiol. Gastrointest. Liver Physiol., 307, G1100–1107.
HallJ.C., PriestleyJ.V., PerryV.H., and Michael-TitusA.T. (2012). Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J. Neurochem., 121, 738–750.
17.
BassoD.M., BeattieM.S., and BresnahanJ.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12, 1–21.
18.
LiX., StaszewskiL., XuH., DurickK., ZollerM., and AdlerE. (2002). Human receptors for sweet and umami taste. Proc. Natl. Acad. Sci. U. S. A., 99, 4692–4696.
19.
ZhaiP.P., XuL.H., YangJ.J., JiangZ.L., ZhaoG.W., SunL., WangG.H., and LiX. (2015). Reduction of inflammatory responses by L-serine treatment leads to neuroprotection in mice after traumatic brain injury. Neuropharmacology, 95, 1–11.
20.
MaralaniM.N., MovahedianA., and JavanmardS.H. (2012). Antioxidant and cytoprotective effects of L-Serine on human endothelial cells. Res. Pharm. Sci., 7, 209–215.
21.
McDonaldP.P., BaldA., and CassatellaM.A. (1997). Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood, 89, 3421–3433.
22.
MiskolciV., RollinsJ., VuH.Y., GhoshC.C., DavidsonD. and VancurovaI. (2007). NFkappaB is persistently activated in continuously stimulated human neutrophils. Mol. Med., 13, 134–142.
23.
WrightH.L., MootsR.J., BucknallR.C., and EdwardsS.W. (2010). Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford), 49, 1618–1631.
WhalleyK., O'NeillP., and FerrettiP. (2006). Changes in response to spinal cord injury with development: vascularization, hemorrhage and apoptosis. Neuroscience, 137, 821–832.
26.
GenoveseT., EspositoE., MazzonE., Di PaolaR., CaminitiR., BramantiP., CappelaniA., and CuzzocreaS. (2009). Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J. Neurochem., 108, 1360–1372.
27.
PopovichP.G., WeiP., and StokesB.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol., 377, 443–464.
28.
DonnellyD.J., and PopovichP.G. (2008). Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol., 209, 378–388.
29.
NeirinckxV., CosteC., FranzenR., GothotA., RogisterB., and WisletS. (2014). Neutrophil contribution to spinal cord injury and repair. J. Neuroinflammation, 11, 150.
30.
TrivediA., OlivasA.D., and Noble-HaeussleinL.J. (2006). Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res., 6, 283–292.
31.
FlemingJ.C., NorenbergM.D., RamsayD.A., DekabanG.A., MarcilloA.E., SaenzA.D., Pasquale-StylesM., DietrichW.D., and WeaverL.C. (2006). The cellular inflammatory response in human spinal cords after injury. Brain, 129, 3249–3269.
32.
PanterS.S., YumS.W., and FadenA.I. (1990). Alteration in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol., 27, 96–99.
33.
SimpsonR.K.Jr., RobertsonC.S., and GoodmanJ.C. (1990). Spinal cord ischemia-induced elevation of amino acids: extracellular measurement with microdialysis. Neurochem. Res., 15, 635–639.
34.
NelsonG., ChandrashekarJ., HoonM.A., FengL., ZhaoG., RybaN.J., and ZukerC.S. (2002). An amino-acid taste receptor. Nature, 416, 199–202.
35.
TodaY., NakagitaT., HayakawaT., OkadaS., NarukawaM., ImaiH., IshimaruY., and MisakaT. (2013). Two distinct determinants of ligand specificity in T1R1/T1R3 (the umami taste receptor). J. Biol. Chem., 288, 36,863–36,877.
36.
XuG.Y., HughesM.G., YeZ., HulseboschC.E., and McAdooD.J. (2004). Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp. Neurol., 187, 329–336.
37.
LiuD., XuG.Y., PanE., and McAdooD.J. (1999). Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience, 93, 1383–1389.
38.
BullockR., and FujisawaH. (1992). The role of glutamate antagonists for the treatment of CNS injury. J. Neurotrauma, 9, Suppl. 2, S443–462.
39.
LawrenceT. (2009). The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol., 1, a001651.
40.
MorganM.J., and LiuZ.G. (2011). Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 21, 103–115.
41.
ZhouY., RenJ., SongT., PengJ., and WeiH. (2016). Methionine regulates mTORC1 via the T1R1/T1R3-PLCbeta-Ca2+-ERK1/2 signal transduction process in C2C12 Cells. Int. J. Mol. Sci., 17, 1684.
42.
WausonE.M., GuerraM.L., DyachokJ., McGlynnK., GilesJ., RossE.M., and CobbM.H. (2015). Differential regulation of ERK1/2 and mTORC1 through T1R1/T1R3 in MIN6 cells. Mol. Endocrinol., 29, 1114–1122.
43.
WeichhartT., HengstschlagerM., and LinkeM. (2015). Regulation of innate immune cell function by mTOR. Nat. Rev. Immunol., 15, 599–614.
44.
HakkimA., FuchsT.A., MartinezN.E., HessS., PrinzH., ZychlinskyA., and WaldmannH. (2011). Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat. Chem. Biol., 7, 75–77.
45.
SimardF.A., CloutierA., EarT., VardhanH., and McDonaldP.P. (2015). MEK-independent ERK activation in human neutrophils and its impact on functional responses. J. Leukoc. Biol., 98, 565–573.
46.
BhattacharyaA., WeiQ., ShinJ.N., Abdel FattahE., BonillaD.L., XiangQ., and EissaN.T. (2015). Autophagy is required for neutrophil-mediated inflammation. Cell Rep. 12, 1731–1739.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
